Jacques Galipeau | Immunology and Microbiology | Research Excellence Award

Published on by Forensic Scientist

Dr. Jacques Galipeau | Immunology and Microbiology | Research Excellence Award

University of Wisconsin-Madison | United States

Dr. Jacques Galipeau is a leading translational immunologist recognized for seminal contributions to mesenchymal stromal cell (MSC) biology, immune modulation, and engineered cytokine therapeutics. His research has reshaped global understanding of MSC immunogenicity, functional potency, and clinical limitations, directly influencing regulatory science and advanced cell therapy development. He pioneered the discovery and translation of fusokines, a novel class of synthetic cytokines with applications in autoimmunity, cancer immunotherapy, transplantation tolerance, and regenerative medicine. His work bridges mechanistic immunology and first-in-human translation, with sustained impact across academia and clinical development. According to Google Scholar, Dr. Jacques Galipeau has authored 478 peer-reviewed publications, received 23244 citations, and holds an h-index exceeding 71, reflecting sustained global influence.

                        Citation Metrics (Google Scholar)

30000

25000

20000

15000

10000

5000

0

 

Citations
23444
Documents
478
h-index
71

Citations

Documents

h-index

View Google Scholar Profile

Featured Publications


Mesenchymal stromal cells: clinical challenges and therapeutic opportunities

– J. Galipeau, L. Sensébé · Cell Stem Cell, 2018 · Cited by 1868


Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages

– J.S. Wang, D. Shum-Tim, J. Galipeau et al. · J Thorac Cardiovasc Surg, 2000 · Cited by 976


Mesenchymal stem versus stromal cells: ISCT® position statement on nomenclature

– S. Viswanathan, Y. Shi, J. Galipeau et al. · Cytotherapy, 2019 · Cited by 866

Human MSC suppression correlates with cytokine-induced IDO and M2 macrophage differentiation

– M. François, R. Romieu-Mourez, M. Li, J. Galipeau · Molecular Therapy, 2012 · Cited by 862

Allogeneic marrow stromal cells are immune-rejected by MHC-mismatched recipients

– N. Eliopoulos, J. Stagg, L. Lejeune et al. · Blood, 2005 · Cited by 700

Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Published on by Forensic Scientist

Mrs. Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University | Poland

Mrs. Monika Prylińska-Jaśkowiak is an emerging clinician-scientist whose professional journey reflects a rare balance between medical practice, academic excellence, and translational research. She earned her Doctor of Medical Sciences degree from Collegium Medicum, Nicolaus Copernicus University in Toruń, where her doctoral research focused on the relationship between the gut microbiome and chronic fatigue syndrome, integrating clinical insight with advanced molecular and bioinformatic analyses. As a specialist pediatrician at the Voivodeship Children’s Hospital in Bydgoszcz, she combines her research background with everyday patient care and is currently pursuing specialization in pediatric rheumatology. Her scientific contributions include peer-reviewed publications such as The gut microbial composition is different in chronic fatigue syndrome than in healthy controls (Scientific Reports, 2025), and review papers in the Journal of Education, Health and Sport (2022), widely cited for summarizing current knowledge on CFS/ME and human gut microbiota. Mrs. Monika Prylińska-Jaśkowiak’s research interests encompass pediatric immunology, microbiome–immune interactions, and chronic inflammatory diseases, with a focus on precision diagnostics and targeted therapy development. Actively engaged in professional societies including the Polish Pediatric Society and the Polish Society of Vaccinology, she continues to expand her expertise through certified courses in resuscitation, vaccinology, and emergency pediatrics. Her commitment to continuous learning, clinical excellence, and evidence-based innovation exemplifies the spirit of a modern physician-scientist dedicated to improving child health and advancing medical science.

Profile: ORCID | LinkedIn

Featured Publications

• Prylińska, M., & Kożuchowski, M. (2022, September 28). The human gastrointestinal tract microbiota in health – current knowledge summary. Journal of Education, Health and Sport, 12(10). https://doi.org/10.12775/JEHS.2022.12.10.005

• Kożuchowski, M., & Prylińska, M. (2022, April 30). The proper functioning of the sense of smell and its disturbances on the example of COVID-19 infection. Journal of Education, Health and Sport, 12(4). https://doi.org/10.12775/JEHS.2022.12.04.026